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ABSTRACT:  Cerebral hypoperfusion during cardiopulmonary bypass surgery has been thought to be
a factor in the aetiology of brain damage with evidence of post-operative neurological deficits. Cardiac-
specific biomarkers such as troponin-I, troponin-T and CK-MB have been used extensively to predict
myocardial injury and ischaemia. This prospective study investigateed the level of troponin-I release in
both off-pump and CPB-technique CABG surgery, as well as postulated a relationship of troponin
release and post-operative neurological outcome. A total of 44 adult patients undergoing coronary
artery bypass graft (CABG) were enrolled into either an off-pump or on-pump groups, with 22 patients
participating in each. Group A (on-pump) underwent myocardial revascularisation with CPB and
cardioplegic arrest, while Group B (off pump) underwent beating heart surgery. The measurement of
troponin-I is a 1-step enzyme immunoassay method, with specificity and sensitivity set at 0.4 ug/mL.
Neurological assessment was done using the NIH Stroke Scale, and neuropsychologic assessment was
assessed on cognitive function using modified Weschler Memory Scale, for which scores were
standardized to achieve a composite measure of concentration. A set of statistical analysis was done to
correlate troponin-I release with different surgical techniques of CPB and OPCAB. Although each
independent technique showed a marked rise of troponin-I from baseline to 6 hours post-operatively,
the difference in troponin release was not significant between the 2 groups at specified time intervals
(p=0.124). There was however a significant correlation of troponin-I release with the number of grafts
used in the surgery, irrespective of the type of grafts or surgical technique. None of the patients in either
group showed any neurological or cognitive deficits presenting at day 3 and day 7 post-operatively. The
findings of this study demonstrate that there is no significant short-term cognitive or neurological
dysfunctions post-operatively, as indicated by troponin-I release in assessing the severity of myocardial
injury.
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INTRODUCTION
Cerebral damage associated with cardiac surgery has
been extensively studied and this has been
comprehensively reviewed (1-3). Cerebral
hypoperfusion during cardiopulmonary bypass surgery
has long been thought to be a factor in the aetiology of
brain damage with evidence of post-operative
neurological deficits (2,3). Cerebral injury may also
occur in the early post-operative period, or alternatively,
any intraoperative damage may be exacerbated by
hypoperfusion at this stage. 89 McGill Journal of Medicine 2006
Previous studies have shown that cardiac surgery
using extracorporeal circuit, also known as the
cardiopulmonary bypass (CPB) technique, is associated
with higher intraoperative myocardial damage and
hence consecutively, worse cerebral hypoperfusion (4-
6). There is a general consensus recently to undertake
off-pump or beating heart coronary artery bypass graft
(CABG) surgery with prospective aim that by avoiding
CPB, cerebral and other complications should be
limited. However, the incidence of cerebral
complications after cardiac surgery varies considerably
depending on the patients' demographical
characteristics such as age, timing of the post-operative
assessment, sensitivity of the assessment procedures
and whether prospective or retrospective study
procedures were used (7).
Current research showed that apart from a higher
incidence of cerebral hypoperfusion and ischaemia,
CPB produces numerous important causes of
myocardial damage such as atriotomy, poor myocardial
protection, duration of aortic cross-clamping,
myocardial stunning; as well as myocardial ischaemia
and infarction (7-9). During cardiac operations with
CPB, the heart is arrested and protected using
cardioplegia; during this period the heart is rendered
ischaemic. At the end of CPB, the heart is reperfused
and the cardiac action resumes. This reperfusion after
ischaemic period produces myocardial damage and
eventual necrosis. By contrast, during an off-pump
cardiac surgery, the heart keeps beating and thus
reperfusion injury is avoided. 
Cardiac-specific biomarkers such as troponin-I,
troponin-T and CK-MB, have been used extensively
until recently, to predict myocardial injury and
ischaemia (10-15). Troponin-I is solely confined to the
myocardium and has been shown to be a highly specific
marker for the detection of myocardial injury.
The aim of this prospective study was to investigate
the level of troponin-I release in both off-pump and
CPB-technique CABG surgery, and determine whether
there is a significant myocardial injury associated with
CPB, as suggested by the literature. This study also
scrutinised the relationship of troponin-I with post-
operative neurological sequelae in both CPB and
OPCAB groups.
METHODS
This study was carried out in Department of
Cardiothoracic Surgery, All India Institute of Medical
Sciences, with subsequent data revision done in the
New Royal Infirmary of Edinburgh. The study was
approved by the Indian Medical Research, New Delhi.
A total of 44 adult patients undergoing coronary
artery bypass graft (CABG) were enrolled into either an
off-pump or on-pump groups, with 22 patients
participating in each. Group A (on-pump) underwent
myocardial revascularisation with CPB and
cardioplegic arrest, while Group B (off pump)
underwent beating heart surgery. Age boundaries were
set at 16 and 85 years. On preoperative admission, the
study was fully discussed with the patient, clerking on
history and clinical examination performed. Pre-
operative documentation included patient's age, gender,
patient's pathology, operation planned, anti-platelet
therapy given within seven days, pre-operative anti-
coagulation and bleeding history. The inclusion criteria
for patients in the study were; stable angina not suitable
for balloon angioplasty or stenting, with two or more
vessel disease.  Exclusion criteria were the inability to
provide informed consent, acute infections, severe
ongoing neurological dysfunctions, impaired left
ventricular fraction with ejection fraction of less than
30%, recent myocardial infarction within 1 month,
acute renal failure, previous stroke or transient
ischaemic attack, coagulopathy, emergency/ redo
surgery and surgical re-exploration. This study
conforms to the Declaration of Helsinki as regards
medical research on human subjects as well as local
ethical requirements.
Patient management
Standard monitoring was instituted prior to surgery;
arterial line, central venous pressure, ECG, urinary
catheter and nasal temperature.  
All previous cardiac medications were continued up to
the day of surgery, except aspirin and clopidogrel,
which were stopped a week before the operation.
Anaesthetic agents used were kept standard for all
patients in both groups. Intravenous anaesthesia with
propofol infusion 3mg.kg.hour and fentanyl 1
mg/kg/min were given at induction. Neuromuscular
blockage was achieved by pancuronium bromide 0.15
mg.kg and lung ventilation was maintained as
normocapnia with oxygen and air, without positive end
expiratory pressure (PEEP). 
Intraoperative evaluations were recorded on
haemodynamic stabilility of the patients, the type and
number of grafts used, the duration of the surgery, and
specifically in CPB group, the duration of the CBP and
aortic cross-clamp time. 
Body surface area was calculated as a variable in
patient demographic data, using the Dubois and Dubois
Formula:
Body surface area (m2) = 0.20247 x height (m)0.725 x weight (kg)0.425
Operative technique
Standard open-heart technique was  performed for all
patients through total median sternotomy.  In patientsTroponin-I Release 90 Vol. 9  No. 2
undergoing surgery with CPB,  heparin was added to the
pump prime at a concentration of 1iu/ml. Prior to the
institution of cardiopulmonary bypass (CPB) heparin
was administered to the patient at a dosage of 300iu/Kg
sufficient to raise the accelerated clotting time (ACT) to
above 480 seconds. Whilst on CPB supplemental
heparin was administered as required to maintain the
ACT above this level. CPB was established with a roller
pump, the use of a flexible venous reservoir with vent
and cardiotomy suction. Systemic cooling was carried
out to 28-32 C. Cold blood cardioplegia was used
following application of the aortic cross clamp to
achieve cardiac arrest. Once rewarming to 37 C was
completed and CPB discontinued, protamine sulphate
was given to reverse systemic heparinisation. Where the
ACT remained above 140 seconds supplemental
protamine was given. All pump blood remaining, except
for that contained within the extra-corporeal circuit, was
returned to the patient. After weaning from CPB, mean
arterial pressure was maintained above 60 mmHg with
appropriate vasoactive drugs.
In group A, the proximal grafts anastomoses were
performed during aortic cross-clamp, and distal
anastomoses followed subsequently. For off-pump
group (Group B), Octopus device stabiliser were used
only once during the graft anastomoses, with mean
arterial pressure always greater than 65mmHg
throughout the surgery to maintain haemodynamic
stability.  Heparin was administered at dosage of 1
mg/kg, protamine sulphate was not given for reversal of
heparinisation. The temperature was set to be
normothermia at 36 C. Intraoperative time was recorded
from the beginning of sternotomy until the end of last
distal anastomoses, whereas the surgery time was
defined from the start of induction until transfer to the
intensive care unit.
Thoracic drains were placed in the mediastinum, left
and right pleural cavities where required. Post-operative
suction was maintained at 20cm/H2O. All red cell
transfusions were carried out as per local protocol.
Crystalloid was given in the intensive care at a rate of
0.5mls/Kg with colloid administered where required. 
Troponin-I Measurements
The measurement of troponin-I is a 1-step enzyme
immunoassay method, with specificity and sensitivity
of 0.4 ug/mL. The specificity with minimum value
above 0.4ug/ml is necessary to indicate positive value.
Serial measurements were taken at specified time from
the arterial line. For patients undergoing surgery with
CPB, measurements were taken at induction, 20
minutes after the start of CPB, at skin closure, 6 hours
and 24 hours post-operatively. In OPCAB group,
measurement was taken at induction, after the distal
anastomosis of the graft conduits, at skin closure, 6
hours and 24 hours post-operatively. During the surgery,
inspection was made on the condition of the aorta;
patients who presented with abnormalities such as
atherosclerotic plaque were excluded from the study.
Pre-operative and post-operative evaluations 
Post-operative assessment was recorded into 2
components at day 3 post-operatively: 1) general
observation on duration of ICU stay, post-operative
ECG changes and re-exploration; 2)neurologic and
neuropyshologic assessment. Neurological assessment
was done using the NIH Stroke Scale, with patient
diagnosed with acute neurological dysfunction if the
criteria is above 10 (total score of 22). Any abnormal
score would indicate cognitive dysfunction post-
operatively, provided the baseline score at pre-operative
was normal.
A standardized neurologic examination was done
using the NIH Stroke Scale which assessed mentation,
cranial nerve function, motor power, reflexes,
sensation/cerebellar function, and gait, with 14
individual elements graded on a scale from 0 to 3 for a
possible total of 42 was performed the day before the
surgery. A score of more than 10 on total baseline
assessment was identified as indicating preoperative
neurologic dysfunction. Neuropsychologic assessment
was done on cognitive function of the patient using
modified Weschler Memory Scale, for which scores
were standardized and averaged to achieve a composite
measure of concentration.
RESULTS
Clinical characteristics
The patients' demographic data are shown in Table-2.
A total of 44 patients were recruited for the study. One
patient in CPB group had to be re-explored due to
massive bleeding at day 1 post-operatively. None of the
other patients in both groups had any serious bleeding
through nose, gastrointestinal tract or urine catheter. 
Serial troponin-I measurements
Below is the troponin values at each time interval of
induction, intraoperative (20 minutes after start of CPB
in CPB group, after distal anastomosis in OPCAB
group), at skin closure, 6 hours and 24 hours post-
operatively. 
Table 1.Demographic and pre-operative data (n=22 in each group)
Variable OPCAB group CPB group p value
Age 59.6± 8.5 59.1± 9.1 NS
Sex 13 males (60%), 15 males (70%),91 McGill Journal of Medicine 2006
9 females (40%) 7 females (30%) NS
Weight 67.0 ± 7.2 kg 65.9 ± 8.2 kg NS
Height 163.5 ± 7.9 cm 161.7 ± 8.0 cm NS
Body  1.57±0.83 1.60± 0.26 NS
surface area (m
2)
Preoperative              60% ± 0.3 59% ± 0.1  NS
ejection fraction 
Preoperative  7 9
myocardial infarction
X-Clamp - 35.1 ± 10.6 minutes
CPB time - 56.6 ± 17.9 minutes
Minimum Temp 31.7 ± 1.5 oC
Max rewarming Temp 37.2 ± 0.32 oC
Prothrombin time 1 1 NS
Table 2.Intraoperative and Post-operative Data
Variables OPCAB CPB
LIMA graft 22 22
Saphenous vein grafts 20 21
Grafts anastomoses  3.2 ± 0.5 3.8 ± 0.1
per patient
Ventilation time (min) 38.4 ± 13 45.7 ± 20
Post-operative  52% ± 0.2 56% ± 0.3
ejection fraction ( % )
Sternal infection 2 1
Leg wound infection 1 1
Length of ICU stay (days) 1.5 ± 0.8 1.6 ± 0.5
Length of total  7.6 ± 2.0 6.6 ± 1.8
hospital stay (days)
7-day mortality 0 0
Table 3. Troponin-I values for both groups
Time Interval OPCAB (ug/ml) CPB (ug/ml)
Induction 0 ± 0 0±0
Intra-operative 0.65 ±0.85 1.35± 0.75
Skin closure 2.05 ±1.57 2.35 ±1.16
6 hours 2.10± 1.56 5.20 ±6.10
24 hours 1.95 ± 1.69 4.55 ± 5.67
Another set of analysis was made to see the
correlation of troponin-I with different surgical
techniques of CPB and OPCAB. Surprisingly, although
each independent technique showed a marked rise of
troponin-I from baseline to 6 hours post-operatively, the
troponin release was not significant between the 2
groups at specified time intervals (p=0.124). Hence,
when troponin-I is used as a cardiac biomarker for
myocardial injury, troponin release in both groups do
not reflect whether one technique is superior to the other
based on short term cardiac clinical outcomes. In CPB
group, there was no significance between post-operative
troponin release with the duration of CPB or the aortic
cross-clamp time (p>0.05).
Troponin level rise was almost uniform in both
groups. This exception was noted in one patient in CPB
group, where her post-operative 6 hours level was
22ug/ml. This patient had severe syncope preceded by
palpitation 2 weeks prior to surgery, diagnosed as sick
sinus syndrome and was put on temporary pacemaker
up to the day of operation. The patient had bilateral
renal artery stenosis and 2 episodes of myocardial
infarction within a year prior to surgery. Although her
baseline troponin-I was undetected, it was concluded
that her co-morbidity prior to surgery contributed to
significant myocardial injury intra-operatively.
Number of grafts and troponin-I release
There was a significant correlation of troponin-I
release with the number of grafts used in the surgery,
irrespective of the type of neither the grafts nor the
surgical technique. Graph below shows the statistical
correlation between the number of grafts and the
troponin release at 6 hours post-operatively. (Figure 2;
60% Pearson Correlation with p=0.005).
Post-operative evaluations
On general observation, there was a longer ICU stay
Fig-1:Troponin-I Level at Specified Time Intervals
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in patients with higher troponin release at 6 hours after
closure (Pearson Correlation 79.2%, p<0.05). However,
upon specific observations, it was noted that the length
of ICU stay was not entirely determined by patients'
haemodynamic stability, but also dependent on bed
availability and date of transfer to the ward. Therefore,
other factors should be kept into considerations before
troponin is used as a sole predictor to determine
patients' haemodynamic stability and length of ICU
stay.
Patients in both groups underwent thorough
neurologic and neuropsychologic clinical assessment at
day 3 and day 7 after surgery. None of the patients in
both groups showed any neurological deficits or
cognitive deficits presenting post-operatively. This
information indicates that any adverse effects on
myocardial injury are normalised and were not followed
by any acute sequelae, representing deficit of operative
procedures. With this negative finding on acute
neurological outcomes, there was no significant
relationship on biochemistry evaluation of troponin-I
with acute post-operative neurological outcomes. Long
term neurological outcome was not however being
carried out for the purpose of this study.
DISCUSSION
Although the current consensus is with renewed
interest and in favour of OPCAB technique in cardiac
surgery, there has always been a debate on which
surgical technique is more superior to another, in
reducing the morbidity and mortality owing to
myocardial revascularisation.  One definite advantage
of OPCAB is with increasing surgical demand;
coronary operations could be performed at a lower cost
without the expenses of a cardio-pulmonary bypass
machine. However, a major concern on undertaking an
off-pump approach is the obvious difficulty of
performing the coronary anastomoses on the beating
heart, with an increased risk of intraoperative
myocardial ischaemia and suboptimal anastomoses
performed (17). It goes without saying that achieving
complete revascularisation should be the main priority
of the surgery irrespective of the technique, as
incomplete anastomoses of the grafts is significantly
associated with post-operative mortality rate,
perioperative myocardial infarction, and low cardiac
output (17, 18). It is also  important to consider other
factors when choosing surgical procedure to be
performed; this include surgeon's degree of expertise,
patient population and their pre-existing comorbidities. 
Biochemical markers have been used extensively to
identify the mechanism of myocardial injury associated
with surgical technique and the post-operative
neurological sequelae, for patients who have had
cardiac surgery performed with or without CPB. Recent
literature suggests the superiority of OPCAB technique
versus CPB, with relations to reducing morbidity and
mortality associated with myocardial injury and
cerebral hypoperfusion associated with the use of
extracorporeal circuit of CPB (4, 5). Hypoperfusion
during CPB is hypothesised to be related to
microembolism and inflammatory changes that lead to
increase in blood-brain barrier permeability, resulting in
cerebral oedema. Hence, this study was carried out to
confirm the previous results and to determine if there
are any acute post-operative neurological deficits in
CPB group.
The finding of this study does not support the current
consensus, as we found that although there is a definite
rise of troponin-I in both groups 6 hours after sternal
closure, there is no significant difference in troponin
release between CPB and OPCAB groups. It is
important to note that there are multiple factors
involved in contributing to inflammatory injury, apart
from CPB, such as surgical trauma, ischaemic-
reperfusion injury and thrombin activation (19).
Surgery alone may activate haemostatic responses,
activation of immune mechanisms and inflammatory
responses mediated by the release of various cytokines
and chemokines. Hence as seen in this study, the rise in
troponin was almost uniform post-operatively in both
group, with definite evidence of myocardial injury as
the result of surgery itself. 
With respect to inflammatory response, it is difficult
to draw a conclusion on the extent of myocardial injury
based on biochemical parameters alone, as there are
other several confounding factors that may interplay in
determining the ultimate haemostatic derangement. The
threshold for inflammatory mediator release is also
determined by patient individual risk stratification,
protocol of heparin and protamine administration,
anaesthesiologic techniques, and the expertise of the
surgeon operating the cases. Hence troponin rise in this
study does not indicate a direct correlation between the
inflammatory response and the actual physiologic
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mechanisms.  
The study by Ascione et al suggests that complement
activation of IL-6 is similar in both off-pump and on-
pump patients after the cardiac surgery (20). This
evidence is important to support the concept that
surgical injury per se triggers release of acute-phase
reactants, with possible impact on clinical
consequences. 
On a positive note, the statistical analysis however
shows that irrespective of the surgical procedure, there
is a significant positive correlation between the number
of grafts performed in the surgery with 6-hour post-
operative troponin-I release. (60% Pearson Correlation
with p=0.005). Considering that the duration of the
surgery increases on linear pattern with the number of
grafts for each case, it is not surprising that myocardial
injury is significantly higher in relation to the actual
operation time, and the extent of anastomoses done
directly on the myocardium. There is no significant
difference between the troponin release and the type of
grafts performed, such as LIMA, saphenous vein artery
or radial grafts. 
The evaluation of postoperative morbidity shows
positive correlation between the rise of troponin after 6
hours post-operatively and the length of ICU stays in
both groups of patients.  Despite the optimism to use
troponin as a biomarker for acute post-operative
neurological deficit, the population of the study did not
show any acute, evolving neurological symptoms as the
result of the surgery. More follow-ups are needed to
investigate whether these patients may show significant
clinical signs on long term outcome. It should be
emphasised that apart from clinical evaluation, there is
a lack of effective methodology or marker for assessing
neurologic and cognitive dysfunctions after cardiac
surgery.
At present, more analysis is needed to explore the
surgical complications of these patients, in terms of
graft patency for CPB versus OPCAB groups, and also
long term prospective neurological outcome after CPB-
technique, as suggested by previous studies.  Major
postoperative complications such as in-hospital
mortality was rare, hence large cohort studies would be
needed to identify those aspects between the two groups
in order to achieve positive statistical differences. 
The findings of this study demonstrate that there is no
proven significant short term cognitive or acute
neurological dysfunctions post-operatively, as indicated
by troponin-I in assessing the severity of myocardial
injury, within the scope of our research. Although this
contradicts the popular belief that off-pump surgery
reduces morbidity and mortality rate, these observations
may encourage a larger cohort in the future to improve
our understanding on the actual mechanism of
myocardial injury, without omitting the judicious
stratification of the patient's pre-existing clinical
condition in determining the most appropriate surgical
technique for their own optimal outcome. 
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